Nasdaq:NTRB
NutriBand Inc.
NTRB is a Nasdaq-traded developer of health wearables and nutritional tech targeting the direct-to-consumer wellness market.
Key Metrics
Investment Thesis
Bull Case
NTRB offers exposure to the high-growth health tech sector with a unique niche in combining wearables with personalized nutrition, a trend expected to expand significantly. The company's balance sheet shows positive cash equivalents of $4.3M and manageable current liabilities, providing some runway for strategic pivots if new revenue channels are unlocked. Early-stage investors may view the substantial R&D spend of $3.1M as an investment in future product differentiation that could eventually drive scalable profitability.
Bear Case
The stock is fundamentally distressed with a consistent loss trend deepening from -$4.5M to -$10.5M over the last five years, signaling severe operational inefficiencies. With revenue flatlining at $2.1M while expenses skyrocket, the company is unlikely to achieve breakeven without a major shift in business model or massive capital infusion. Investors should avoid NTRB given the high risk of dilution from frequent share issuances and the potential for insolvency if financing markets tighten.
About NutriBand Inc.
NutriBand Inc. (NTRB) develops and sells health-focused wearable technology and nutritional solutions designed to optimize user wellness metrics. The company primarily serves the direct-to-consumer fitness market with a focus on personalized tracking devices that integrate dietary data. Recent financials highlight a stable revenue plateau around $2.1M while navigating significant operational losses.
Analysis
Management Discussion
Management has stabilized revenue at $2.1M across 2023 through 2025 but faces an intensifying profitability challenge with operating profits declining to -$10.3M in the latest period. Despite positive cash flows from financing activities of $8.5M and share issuances, operational cash flow remains negative at -$4.6M, suggesting that organic operations are not yet self-sustaining. The significant non-cash adjustments of $5.9M indicate heavy reliance on accounting entries to manage reported earnings while actual liquidity generation struggles against high depreciation and amortization costs.
Industry Overview
The global health technology market is experiencing robust growth driven by consumer demand for preventative care and personalized wellness solutions. However, competition is fierce among wearable manufacturers, creating a crowded landscape where only companies with strong unit economics can sustain long-term operations. Regulatory scrutiny on data privacy and health claims also adds complexity to the operating environment for firms like NutriBand.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $2.1M | $2.1M | $2.1M |
| Cost of Revenue | $1.3M | $1.2M | $1.4M |
| Gross Profit | $750.4K | $862.1K | $743.3K |
| Operating Expenses | $5.2M | $5.7M | $11.0M |
| Operating Income | $-4.5M | $-4.9M | $-10.3M |
| R&D | $982.2K | $2.0M | $3.1M |
| G&A | $3.9M | $3.8M | $4.3M |
| Stock-Based Comp | — | $499.9K | $1.4M |
| D&A | $330.1K | $287.7K | $285.1K |
| Depreciation | $183.7K | $174.6K | $171.9K |
| Amortization | $146.5K | $113.2K | $113.2K |
| Other OpEx | $327.3K | $0 | $3.6M |
| Non-Operating Income | $-8.3K | $-613.4K | $-197.8K |
| Interest Expense | — | $75.8K | — |
| Interest Income | — | $16.9K | $191.7K |
| Pre-Tax Income | $-4.5M | $-5.5M | $-10.5M |
| Income Tax | $-5.4M | $-4.3M | $-12.7M |
| Continuing Ops | $941.5K | $-1.2M | $2.2M |
| Discontinued Ops | $-5.4M | $-4.3M | $-12.7M |
| Net Income | $-4.5M | $-5.5M | $-10.5M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-4.5M | $-5.5M | $-10.5M |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $2.7M | $1.0M | $4.8M |
| Cash & Equivalents | $2.0M | $492.9K | $4.3M |
| Accounts Receivable | $113.0K | $148.6K | $73.8K |
| Inventory | $229.3K | $168.6K | $212.0K |
| Other Current Assets | $365.9K | $211.7K | $196.7K |
| Long-Term Assets | $6.8M | $6.5M | $2.7M |
| PP&E (Net) | $897.7K | $774.9K | $695.1K |
| Intangibles | $780.4K | $667.3K | $261.1K |
| Goodwill | $5.0M | $5.0M | $1.7M |
| Operating Leases | $62.8K | $31.4K | — |
| Other LT Assets | $0 | $0 | $0 |
| Total Assets | $9.5M | $7.5M | $7.5M |
| Current Liabilities | $748.6K | $999.1K | $982.8K |
| Current Leases | $31.3K | $34.3K | — |
| Deferred Revenue | — | — | $155.9K |
| Other Current Liab | $717.3K | $964.8K | $827.0K |
| Long-Term Liabilities | $134.8K | $79.8K | $58.2K |
| Total Liabilities | $883.4K | $1.1M | $1.0M |
| Shareholders' Equity | $8.6M | $6.4M | $6.4M |
| Paid-In Capital | $31.1M | $34.4M | $45.0M |
| Retained Earnings | $-22.5M | $-28.0M | $-38.5M |
| AOCI | $-304 | $-304 | $-304 |
| Treasury Stock | $32.6K | $32.6K | $148.5K |
| Total L&E | $9.5M | $7.5M | $7.5M |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $-4.5M | $-5.5M | $-10.5M |
| Non-Cash Adjustments | $1.4M | $1.9M | $5.9M |
| Working Capital Changes | $50.3K | $101.2K | $-58.7K |
| Cash from Operations | $-3.0M | $-3.5M | $-4.6M |
| Capital Expenditures | $79.3K | $51.8K | $92.0K |
| Cash from Investing | $-79.3K | $-51.8K | $-92.0K |
| Cash from Financing | $160.1K | $2.1M | $8.5M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-2.9M | $-1.5M | $3.8M |
| Beginning Cash | $4.9M | $2.0M | $492.9K |
| Ending Cash | $2.0M | $492.9K | $4.3M |
Frequently Asked Questions
How does NutriBand Inc. make money?
The company's revenue streams include hardware sales for its proprietary wearable bands, software subscriptions for data analytics, and licensed nutritional plans derived from user biometric feedback. Operations are split between product manufacturing costs, R&D for new sensor technology, and general administrative expenses related to marketing and distribution.
What are the main risks for NTRB?
The company is currently burning cash at a rate of $10.5M annually, leading to an accumulated deficit of nearly $38.5M which poses a liquidity risk if financing dries up. Revenue has stagnated at $2.1M for the last three years, indicating an inability to capture significant market share or grow top-line growth. High operating expenses totaling over $11M significantly outpace revenue, resulting in consistent net losses that erode shareholder value. Dependence on a small customer base and potential supply chain disruptions for hardware components are additional vulnerabilities.
What is NTRB's competitive advantage?
NutriBand leverages a unique proprietary algorithm that combines real-time biometric data with personalized dietary recommendations to create a sticky ecosystem for health-conscious users. The company maintains a lean cost structure with minimal long-term liabilities relative to its total equity base, preserving capital for strategic R&D investments. Its direct-to-consumer model allows for rapid iteration on product features based directly on customer feedback loops.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.